Exome and Array Data Combined Rival Whole-Genome Sequencing for Most Pharmacogenes
Combining whole-exome sequencing with imputed genotyping array data matched whole-genome sequencing results for 25 of 33 pharmacogenes in UK Biobank ...
Combining whole-exome sequencing with imputed genotyping array data matched whole-genome sequencing results for 25 of 33 pharmacogenes in UK Biobank ...
A 2026 review finds that multi-agonist obesity drugs can produce substantial weight loss, but biomarker and pharmacogenomic tools are not ...
A retrospective multi-omics study associated SRPK1 expression with opposite survival patterns and different predicted chemotherapy responses in breast, colon and ...
A 2026 perspective proposes that large language models could integrate genetic and clinical records to identify possible pharmacogenomic phenoconversion, while ...
A 40-year NHS cost-effectiveness model estimated that CYP2C19-guided dual antiplatelet therapy after PCI was likely cost-effective for STEMI and UA/NSTEMI ...
A comprehensive review argues that drug-induced skin phenotypes can act as early, bedside-visible risk signals of systemic toxicity, identifying specific ...
An exploratory analysis of a randomized trial in locally advanced rectal cancer found that an IL1B gene variant was linked ...
A new Frontiers editorial and eight accompanying studies show how genomic and epigenomic variation is reshaping biomarker discovery, interpretation and ...
A new review argues that diabetes care must move beyond standardized protocols toward genotype-guided therapy, spotlighting the GLIS3 gene and ...
Researchers propose that unrecognized drug-drug-gene interactions known as phenoconversion contribute to pain treatment failures and harm in rural older adults, ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine